Connect with us

CNBC

Johnson & Johnson reports $100 million in quarterly sales from Covid vaccine

J&J’s financial results come as the company’s Covid-19 vaccine has been put on pause in the United States.

Published

on

Johnson & Johnson’s coronavirus disease (COVID-19) vaccines are seen at Northwell Health’s South Shore University Hospital in Bay Shore, New York, March 3, 2021.

Shannon Stapleton | Reuters

Johnson & Johnson on Tuesday reported $100 million in first-quarter sales of its Covid-19 vaccine that’s on hold in the U.S. while federal health regulators investigate a rare blood-clotting issue.

In releasing its first-quarter financial results, the company also reported earnings and revenue that beat Wall Street’s expectations.

Here’s how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: $2.59 per share vs $2.34 expected.
  • Revenue: $22.32 billion vs $21.98 billion expected.

The New Jersey-based company’s share price was down slightly in premarket trading following the report.

J&J’s pharmaceutical business, which developed the single-shot Covid vaccine, generated $12.19 billion in revenue, a 9.6% year-over-year increase. The results were driven by sales of the company’s multiple myeloma drug Darzalex and Stelara, a treatment for Crohn’s disease.

The company’s consumer unit, which makes products such as Neutrogena face wash and Listerine, generated $3.5 billion in revenue, down 2.3% from a year earlier. J&J executives told investors the decline is due to an “unfavorable comparison” to last year when people were stockpiling on over-the counter- products due to the virus.

Its medical device unit generated $6.57 billion, a 7.9% increase, as the pandemic recovery improves. The unit was hit hard last year as the pandemic forced hospitals to postpone elective surgeries and Americans stayed home.

J&J Chief Financial Officer Joseph Wolk told CNBC on Tuesday that its three business segments are “healthier” than they were entering the pandemic last year.

The company raised its earnings and revenue guidance for the year. J&J now expects full-year profit of $9.42 to $9.57 per share, compared with its previous forecast of $9.40 to $9.60 per share. It expects revenue between $90.6 billion and $91.6 billion, compared with its prior forecast of $90.5 billion to $91.7 billion.

J&J’s Covid vaccine has been put on pause in the United States after six women developed a rare but potentially life-threatening blood clotting disorder. One woman died and another was in critical condition.

The six women developed the condition known as cerebral venous sinus thrombosis within about two weeks of receiving the shot, U.S. health officials said. CVST is a rare form of stroke that happens when a blood clot forms in the brain’s venous sinuses. It can eventually leak blood into the brain tissues and cause a hemorrhage.

White House chief medical advisor Dr. Anthony Fauci said last week the pause would give U.S. health regulators the time they need to thoroughly investigate the cases and “find some common denominators among the women who were involved.”

Vamil Divan, an analyst at Mizuho Securities, said in a note to investors Tuesday that he expects safety-related concerns of the J&J shot will drive further demand for Pfizer’s mRNA-based vaccine.

During an earnings call with investors, J&J executives said the company is working to “restore the confidence in the vaccine” after the reports of rare blood clots spooked some patients.

“We hope by making people aware [of the risk,] as well as putting clear diagnostic and therapeutic guidelines in place, that we can restore the confidence in our vaccine,” said J&J chief scientific officer Dr. Paul Stoffels.

Wolk told CNBC that the company is working with U.S. regulators to ensure they have all the information they need to make their decision on the use of the J&J vaccine. He said he expects the U.S. to make a decision as early as the end of this week. A key Centers for Disease Control and Prevention panel is scheduled to meet Friday to make a recommendation on the vaccine.

“We remain very confident and we’re hopeful the benefit-risk profile will play out,” he told CNBC’s “Squawk Box,” adding that the company still expects to deliver 100 million doses in the first half of this year should the U.S. investigation on the blood-clot cases “go well.”

Source: https://www.cnbc.com/2021/04/20/johnson-johnson-jnj-earnings-q1-2021.html

johnson-&-johnson-reports-$100-million-in-quarterly-sales-from-covid-vaccine

CNBC

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/earnings/

earnings

Continue Reading

CNBC

International: Top News And Analysis

CNBC International is the world leader for news on business, technology, China, trade, oil prices, the Middle East and markets.

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/us-top-news-and-analysis/

international:-top-news-and-analysis

Continue Reading

CNBC

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

Published

on

© 2021 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by Reuters

Source: https://www.cnbc.com/earnings/

earnings

Continue Reading

Title

Techcrunch4 days ago

South Korean antitrust regulator fines Google $177M for abusing market dominance – TechCrunch

The Korea Fair Trade Commission (KFTC) said on Tuesday it fined Google $177 million for abusing its market dominance in...

Cointelegraph7 days ago

El Salvador’s Bitcoin detractors: Opposition groups gather as crypto law rolls out

While President Bukele enjoys widespread popularity, his law that makes Bitcoin legal tender does not.

Ventureburn1 week ago

Startup partners with Telkom to launch translation platform for SA languages

Telkom has partnered with SA startup Enlabeler to launch an AI platform that translates speech into text and provides transcription...

Entrepreneur2 weeks ago

Why You Should Make Twitter Spaces Part of Your Business Strategy

Twitter's latest feature can help businesses grow their presence on the platform.

Bioengineer2 weeks ago

What factors put Philippine birds at risk of extinction?

Credit: Ça?an ?ekercio?lu The lush forests and more than 7,000 islands of the Philippines hold a rich diversity of life,

Reuters3 weeks ago

Chinese social media platforms to “rectify” financial self-media accounts

China's top social media platforms, Wechat, Douyin, Sina Weibo and Kuaishou, said on Saturday they would begin to rectify irregular...

Ventureburn3 weeks ago

South African startups helping to solve the global challenges

A new generation of entrepreneurs are not only incubating solid startups but are contributing to help solve some of the...

Techcrunch3 weeks ago

The SEC and the DOJ just charged this startup founder with fraud, saying he lied to Tiger and others – TechCrunch

Today, both the U.S. Department of Justice and the Securities and Exchange Commission charged Manish Lachwani, cofounder of a mobile...

Techcrunch4 weeks ago

Blockchain startup XREX gets $17M to make cross-border trade faster – TechCrunch

A substantial portion of the world’s trade is done in United States dollars, creating problems for businesses in countries with a...

ZDNET4 weeks ago

National Australia Bank keeping staff connected with Google Pixel rollout

More than 2,000 Google Pixel devices were issued to NAB's customer contact teams to enable them to support customers remotely.

Review

    Select language

    Trending